TCTR20211220004进行中（未招募）3 期
Immunogenicity and Safety of Pfizer-BionTech COVID-19 vaccine as booster dose(s) in systemic lupus erythematosus and rheumatoid arthritis patients who have been vaccinated with either inactivated SARS-CoV-2 or viral-vector ChAdOx1 nCoV-19 COVID-19 vaccine
Ratchadapiseksompotch Fund, Faculty of Medicine0 个研究点目标入组 100 人开始时间: 2021年12月20日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •Age 18-65 years old Diagnosis of SLE according to American College of Rheumatology (ACR) 1997 or The Systemic Lupus International Collaborating Clinics (SLICC) criteria or or EULAR/ACR classification Diagnosis of RA according to 2010 ACR and European League Against Rheumatism (EULAR) classification criteria for rheumatoid arthritis, who have been vaccinated with either inactivated SARS-CoV-2 or viral-vector ChAdOx1 nCoV-19 COVID-19 vaccine
排除标准
- •Pregnancy, History of SARS-CoV-2 infection
研究者
相似试验
已完成
不适用
Evaluation of a COVID-19 lateral flow self-test: What is the performance of the Panbio™ COVID-19 self-test device when performed by lay users?ISRCTN38930336Abbott Rapid Diagnostics312
进行中（未招募）
不适用
Immunogenicity and safety of COVID-19 vaccines in SLE and rheumatoid arthritis patientsSLERAImmunosuppresive agentsImmunogenicity to SARS-CoV2 vaccinationSLEImmunosuppressive therapyHumoral immune responseCellular immune responseSARS-CoV-2 vaccineRATCTR20210917003Ratchadapiseksompotch Fund, Faculty of Medicine100
尚未招募
不适用
Effect of Covishield vaccine in CKD patients versus healthy individualsCTRI/2022/10/046209JIPMER
尚未招募
不适用
Immunogenicity and safety COVID-19 vaccine in healthy adults: a single institute based cohort studyCOVID-19JPRN-UMIN000043589Saga University60
已完成
1 期
Safety and Immunogenicity of EXG-5003.Prevention for SARS-CoV-2 infection diseaseJPRN-jRCT2041210013Doi Yohei60